850 INDEX
target lesions, erythema multiforme, 274, 281
Tavistseeclemastine
tazarotene, 159
Tazicefseeceftazidime
T-cell lymphomaseecutaneous T-cell lymphoma
Tegopenseecloxacillin sodium
telogen defluxion, 61
telogen hairs, 44, 51
Temarilseetrimeprazine
tepoxalin, 811
terbinafine, 812
for dermatophytosis, 324
forMalasseziadermatitis, 483
precautions, 484
for sporotrichosis, 661
terminology, 11–14,14–27
claw disorders, 588–589
histopathology,39–40
Terramycinseeoxytetracycline
Testexseetestosterone
testicular tumors, 339, 341,345–347
testosterone, 812
testosterone-responsive dermatoses, 61, 339
tetracycline, 812
for claw disorders, 594
for lupus erythematosus, 471
for nocardiosis, 538
for panniculitis, 566
for pemphigus/pemphigoid, 196
for reactive cutaneous histiocytosis, 386
for sebaceous adenitis, 650
for vasculitis, 701
Th 1 /Th 2 /Th 17 cells, 174–175
thrombovascular necrosis, proliferative, 699, 707
thymoma-associated exfoliative dermatitis, feline, 616
clinical features, 61, 62,457,620,632–633
diagnostics, 623
differential diagnosis, 621
footpads, 592, 609
therapeutics, 625
Thyrogenseethyrotropin
thyroid gland biopsy, 420
thyroid hormones, 416–417, 419–420
supplementation, 420, 421–422,428–429
thyroiditis, lymphocytic, 417
thyroid-stimulating hormone (TSH)seethyrotropin
Thyro-Tabsseelevothyroxine
thyrotoxicosis, 421
thyrotropin (TSH), 416, 417, 813
plasma levels, 420, 422
stimulation test, 420–421
thyrotropin-releasing hormone (TRH), 416, 813
stimulation test, 421
L-thyroxineseelevothyroxine
Thytroparseethyrotropin
Tibetan terrier, 744
Ticarseeticarcillin
ticarcillin, 814
ticarcillin + clavulanate, 550, 813
Ticillinseeticarcillin
tick bite dermatitis, 240, 244, 246
clinical features, 242–243, 261
therapeutics, 247
tick bite hypersensitivity, 240, 244, 246
clinical features, 242–243, 262
therapeutics, 247
tick paralysis, 243
ticks, 240, 243, 261
Timentinseeticarcillin + clavulanate
tissue samplingseebiopsy
tobramycin, 814
toceranib phosphate, 499
α-tocopherolseevitamin E
toothbrush technique, sample collection, 29,32, 334
topical hormone replacement therapy, human
clinical features, 61,89,339,348–349, 350
diagnostics, 340
topical therapy
adverse reactions, 266,269,273, 276
for atopic disease, 179
for dermatophytosis, 324, 325, 326
for epitheliotropic lymphoma, 369
for keratinization disorders, 437–438
for lupus erythematosus, 472
forMalasseziadermatitis, 483
for otitis, 549–550
for pyoderma, 142, 151, 217, 220
for sebaceous adenitis, 650
Toradolseeketoroloc tromethamine
touch imprints, 46,54–55
toxic epidermal necrolysis (TEN), 272–275
clinical features, 63,114,274,283–285
toxic shock syndrome toxins, 145
toy fox terrier, 417
toy poodle, 481, 741
traction alopecia, 60, 76
tramadol, 814
Tramisolseelevamisole hydrochloride
transepidermal water loss (TEWL), 10, 431
trauma
clawfold region, 66
footpad sloughing/ulceration, 592, 611
see alsoself-injurious dermatoses
Treglymphocytes, 174, 175
Trentalseepentoxifylline
tretinoin
for acne, 159
for actinic keratosis, 623, 624
for photodermatoses, 578
Trexanseenaltrexone
TRHseethyrotropin-releasing hormone
triamcinolone, 815
for autoimmune blistering diseases, 197
for eosinophilic granuloma complex, 355
for otitis, 550
Triamtabsseetriamcinolone
Tribrissenseetrimethoprim + sulfadiazine
trichoblastoma, 674, 675, 678, 691